Krishna Vaddi, CEO at Prelude Therapeutics Inc (PRLD), bought 106,888 shares at $0.93 ($99K) on 2024-12-18, disclosed to the SEC on 2024-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.93 | 100,000 | $93K | 93.8% |
| 2 | $0.89 | 6,888 | $6K | 6.2% |
| Total | $0.93 avg | 106,888 | $99K | 100% |
| Filing → |
| PRLD | BUY | 2025-03-18 | $29K | — | Filing → |
| PRLD | BUY | 2025-03-14 | $70K | — | Filing → |
| PRLD | BUY | 2025-01-03 | $6K | — | Filing → |